Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUDESONIDE

BUDESONIDE

Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BUDESONIDE is listed in Drugs@FDA under application 209041 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BUDESONIDE Form and strength CAPSULE, DELAYED RELEASE;ORAL - 3MG Sponsor SCIECURE PHARMA INC Submission history Latest submission status date: 2017-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUDESONIDE is listed in Drugs@FDA under application 209041 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUDESONIDE Form and strength CAPSULE, DELAYED RELEASE;ORAL - 3MG Sponsor SCIECURE PHARMA INC Submission history Latest submission status date: 2017-09-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.